Gleolan, also known as aminolevulinic acid hydrochloride, is a medication used in the field of neurosurgery to assist in the visualization of malignant tissue during surgery. This drug is specifically designed to aid in the identification of high-grade gliomas, a type of brain tumor that can be difficult to distinguish from healthy brain tissue during surgery.

Gleolan works by being metabolized by the tumor cells and causing them to fluoresce under a special blue light, allowing surgeons to more accurately identify and remove cancerous tissue while sparing healthy brain tissue. This can lead to more successful surgeries with better outcomes for patients.

It is important to note that Gleolan is not a treatment for brain tumors on its own, but rather a tool to assist surgeons in performing more precise and effective surgeries. It is typically administered orally a few hours before surgery and is well-tolerated by most patients.

As with any medication, Gleolan may have side effects such as nausea, vomiting, and allergic reactions in some individuals. It is important for patients to discuss their medical history and any current medications with their healthcare provider before taking Gleolan to ensure its safety and effectiveness.

Overall, Gleolan has been shown to be a valuable tool in the field of neurosurgery, helping surgeons to more accurately identify and remove malignant brain tumors. If you or a loved one is facing surgery for a high-grade glioma, talk to your healthcare provider about whether Gleolan may be a beneficial addition to your treatment plan.